Description:
The authoritative clinical handbook promoting excellence and best practice
Cardiovascular Prevention and Rehabilitation in Practice is a comprehensive, practitioner-focused clinical handbook
which provides internationally applicable evidence-based standards of good practice. Edited and written by a
multidisciplinary team of experts from the British Association for Cardiovascular Prevention and Rehabilitation
(BACPR), this book is invaluable for practitioners helping people with heart disease return to health. The text
provides an overview of research findings, examines the core components of cardiac rehabilitation, and discusses
how to support healthier lifestyles and reduce the risks of recurrence.
Now in its second edition, this textbook has been fully revised to incorporate recent clinical evidence and align
with current national and international guidelines. Increased emphasis is placed on an integrated approach to cardiac
rehabilitation programmes, whilst six specified standards and six core components are presented to promote sustainable
health outcomes.
practice
supporting psycho-social health, managing medical risk factors, and how to develop long-term health strategies
outcomes, and gives examples of strategies to achieve these
will need to meet common challenges
CHAPTER 1: Cardiovascular Disease Prevention and Rehabilitation
1.1 RATIONALE AND AIMS
1.2 THE BURDEN OF CVD
1.3 DEFINING CR AND CARDIOVASCULAR PREVENTION AND REHABILITATION
더보기
1.4 THE COMPELLING CASE FOR CARDIOVASCULAR PREVENTION AND REHABILITATION
1.5 SERVICE PROVISION AND UPTAKE
1.6 EMPLOYING EVIDENCE‐BASED APPROACHES TO INCREASE PARTICIPATION
1.7 FUTURE PERSPECTIVES
1.8 CONCLUSION
CHAPTER 2: Standards and Core Components in Cardiovascular Disease Prevention and Rehabilitation
2.1 RATIONALE AND AIMS
2.2 SIX STANDARDS TO ACHIEVE HIGH QUALITY CARDIOVASCULAR PREVENTION AND REHABILITATION
2.3 THE CORE COMPONENTS
CHAPTER 3: Delivering Quality Standards
3.1 RATIONALE AND AIMS
3.2 MAINTAINING EVIDENCE‐BASED PRACTICE
3.3 STANDARD 1: THE DELIVERY OF SIX CORE COMPONENTS BY A QUALIFIED AND COMPETENT MULTIDISCIPLINARY TEAM, LED BY A
CLINICAL COORDINATOR
더보기
3.4 STANDARD 2: PROMPT IDENTIFICATION, REFERRAL, AND RECRUITMENT OF ELIGIBLE PATIENT POPULATIONS
3.5 STANDARD 3: EARLY INITIAL ASSESSMENT OF INDIVIDUAL PATIENT NEEDS WHICH INFORMS THE AGREED PERSONALISED GOALS THAT
ARE REVIEWED REGULARLY
3.6 STANDARD 4: EARLY PROVISION OF A STRUCTURED CPRP, WITH A DEFINED PATHWAY OF CARE, WHICH MEETS THE INDIVIDUAL'S
GOALS AND IS ALIGNED WITH PATIENT PREFERENCE AND CHOICE
3.7 CONCLUSION
CHAPTER 4: Health Behaviour Change and Education
4.1 RATIONALE AND AIMS
4.2 HEALTH BEHAVIOUR CHANGE – THEORETICAL FOUNDATIONS
4.3 HEALTH BEHAVIOUR CHANGE – ADDITIONAL CONCEPTS
더보기
4.4 HEALTH BEHAVIOUR CHANGE – TRANSLATING THEORY INTO PRACTICE
4.5 BRINGING IT ALL TOGETHER – GOAL‐SETTING AS A PRACTICAL EXAMPLE
4.6 IMPROVING ADHERENCE TO TREATMENT RECOMMENDATIONS
4.7 THE ROLE OF SOCIAL SUPPORT IN HEALTH BEHAVIOUR CHANGE
4.8 EDUCATION IN CARDIOVASCULAR PREVENTION AND REHABILITATION
4.9 FLEXIBILITY OF APPROACHES TO CARDIOVASCULAR PREVENTION AND REHABILITATION – WHY DO WE NEED A MENU OF OPTIONS?
4.10 MAXIMISING GROUP DYNAMICS – TIPS FOR SUCCESSFUL GROUP SUPPORT
4.11 CLOSED VERSUS OPEN GROUPS
4.12 HOW WILL THE COMPONENT BE ASSESSED AND MONITORED?
4.13 CONCLUSION
CHAPTER 5: Lifestyle Risk Factor Management
INTRODUCTION
CHAPTER 5A: Achieving Long‐term Abstinence from Tobacco Use in Patients in a Cardiovascular Prevention
and Rehabilitation Setting
5A.1 RATIONALE AND AIMS
5A.2 DEPENDENCE ON TOBACCO
5A.3 ASSESSMENT
더보기
5A.4 PROVIDING SUPPORT
5A.5 VARENICLINE
5A.6 NICOTINE REPLACEMENT THERAPY
5A.7 COMBINING VARENICLINE WITH COMBINATION NRT
5A.8 BUPROPION
5A.9 EFFICACY AND SAFETY
5A.10 ELECTRONIC CIGARETTES
5A.11 CONCLUSION
5A.12 COMPONENT LEADERS WITHIN A CPRP
5A.13 WEIGHT GAIN AND SMOKING CESSATION
5A.14 HARM REDUCTION
CHAPTER 5B: Diet and Weight Management
5B.1 RATIONALE AND AIMS
5B.2 INFLUENCES OF DIETARY INTAKE
5B.3 ASSESSMENT METHODS OF DIETARY INTAKE
더보기
5B.4 ASSESSMENT OF BODY COMPOSITION
5B.5 COMPONENTS OF CARDIOPROTECTIVE DIETARY ADVICE
5B.6 WEIGHT LOSS, MAINTENANCE, AND AVOIDANCE OF CYCLING, INCLUDING PHARMACOLOGICAL SUPPORT
5B.7 COMMON MISCONCEPTIONS AND FREQUENTLY ASKED QUESTIONS
5B.8 RELATIONSHIP WITH OTHER LONG‐TERM CONDITIONS
5B.9 CONCLUSION
CHAPTER 5C: Physical Activity and Exercise
5C.1 RATIONALE AND AIMS
5C.2 CONSISTENCY IN COMMUNICATING CONCEPTS TO PATIENTS
5C.3 PHYSICAL ACTIVITY WITHIN THE CONTEXT OF CARDIOVASCULAR HEALTH
더보기
5C.4 MOVING FROM TRADITIONAL TO CONTEMPORARY MODELS OF PHYSICAL ACTIVITY AND REHABILITATION
5C.5 KEY ISSUES FOR EARLY COMMENCEMENT OF EXERCISE
5C.6 EMERGING AREAS RELATED TO ACTIVITY INTENSITY – FROM SEDENTARY BEHAVIOUR, LIGHT MOBILITY, AND MODERATE INTENSITY
TO
HIGH INTENSITY INTERVAL TRAINING
5C.7 ASSESSING FUNCTIONAL CAPACITY AND PHYSICAL ACTIVITY – GUIDANCE, PRESCRIPTION, AND RISK STRATIFICATION OUTCOMES
EVALUATION AND AUDIT
5C.8 STAFFING, CORE, AND QUALITY STANDARDS
5C.9 FUTURE CHALLENGES FOR EXERCISE IN CARDIOVASCULAR DISEASE PREVENTION AND REHABILITATION
5C.10 OVERARCHING GUIDANCE
5C.11 SPECIFIC PHYSICAL ACTIVITY AND EXERCISE GOALS AND GUIDANCE
5C.12 SPECIFIC EXERCISE SESSIONS
5C.13 PROGRAMME OUTCOMES
5C.14 CONCLUSION
CHAPTER 6: Psychosocial Health
6.1 RATIONALE AND AIMS
6.2 PSYCHOLOGICAL FACTORS RELATED TO HEART DISEASE
6.3 DEVELOPING PSYCHOLOGICAL AWARENESS IN TEAMS
더보기
6.4 ASSESSMENT ISSUES
6.5 INTERVENTIONS
6.6 SEXUAL ASSESSMENT AND COUNSELLING
6.7 RUNNING GROUPS
6.8 THE INFLUENCE OF SOCIAL SUPPORT AND HOW WE CAN IMPROVE THIS
6.9 PREPARING FOR THE END OF THE GROUP
6.10 VOCATIONAL INTERVENTIONS
6.11 WHEN TO REFER ON
6.12 CONCLUSION
CHAPTER 7: Medical Risk Management
7.1 RATIONALE AND AIMS
7.2 BLOOD PRESSURE
7.3 LIPIDS
더보기
7.4 LIPID‐LOWERING THERAPY
7.5 DYSGLYCAEMIA
7.6 MEDICAL RISK FACTORS AND OTHER LONG‐TERM CONDITIONS
7.7 CARDIOPROTECTIVE DRUG AND DEVICE THERAPIES
7.8 ACE INHIBITORS/ANGIOTENSIN II RECEPTOR BLOCKERS
7.9 MINERALOCORTICOID RECEPTOR ANTAGONIST
7.10 LOOP DIURETICS
7.11 STATIN THERAPY
7.12 ANTI‐COAGULANT THERAPIES
7.13 IMPLANTABLE DEVICES
7.14 SPECIFIC ISSUES FOR PATIENTS WITH DEVICES
7.15 CARDIOPROTECTIVE THERAPIES AND OTHER LONG‐TERM CONDITIONS
7.16 MEDICAL MANAGEMENT IN ERECTILE DYSFUNCTION
7.17 CONCLUSION
CHAPTER 8: Long‐term Management
8.1 RATIONALE AND AIMS
8.2 PRIMARY CARE SERVICES
8.3 LONG‐TERM MANAGEMENT OF RISK FACTORS
더보기
8.4 SELF‐MANAGEMENT
8.5 SELF‐MONITORING AND TECHNOLOGY
8.6 HEART SUPPORT GROUPS
8.7 CONCLUSION
CHAPTER 9: Audit and Evaluation
9.1 CLINICAL AUDIT IN THE CONTEXT OF RESEARCH AND SERVICE EVALUATION
9.2 ROLE OF NATIONAL AUDITS
9.3 ESTABLISH WHICH FACTORS BEST DETERMINE OPTIMAL ACCESS AND CLINICAL OUTCOME
더보기
9.4 PROFILE AND OUTCOMES OF CR IN THE UK
9.5 MONITORING STANDARDS THROUGH NATIONAL AUDIT
9.6 NCP_CR THROUGH THE BACPR AND NACR
9.7 ONGOING AND FUTURE RESEARCH
9.8 CONCLUSION
CHAPTER 10: Future Prospects and International Perspectives
10.1 FUTURE PROSPECTS (JOE MILLS)
10.2 COMMONWEALTH AND INTERNATIONAL PERSPECTIVES ON APPLICATIONS OF BACPR STANDARDS AND CORE COMPONENTS
10.3 AUSTRALIAN CARDIOVASCULAR HEALTH AND REHABILITATION ASSOCIATION PERSPECTIVES O